campath
Showing 1 - 17 of 17
Hodgkin Lymphoma, DLBCL Trial run by the NCI (campath, Rituximab, EPOCH)
Completed
- Hodgkin Lymphoma
- Diffuse Large B-Cell Lymphoma
- Campath
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 11, 2022
Kidney Transplantation, Kidney Diseases, Kidney Failure Trial in London (Campath, Daclizumab)
Completed
- Kidney Transplantation
- +2 more
- Campath
- Daclizumab
-
London, United KingdomWest London Renal and Transplant Centre, 4th Floor Ham House, Ha
Sep 1, 2021
Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (haploidentical stem cell transplant,
Recruiting
- Sickle Cell Disease
- haploidentical stem cell transplant
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 18, 2022
Mycosis Fungoides, Sezary Syndrome Trial run by the NHLBI (A matched peripheral donor stem cells, cyclosporine, fludarabine)
Completed
- Mycosis Fungoides
- Sezary Syndrome
- A matched peripheral donor stem cells
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 2, 2020
Campath-1h Phase I/II Pilot Trial as Immunoablative Therapy for
Withdrawn
- Scleroderma
- Campath
-
Los Angeles, CaliforniaChildrens Hospitla Los Angeles
Jan 5, 2019
Leukemia, Lymphoma, Myeloma Trial in Chicago (Busulfan, Fludarabine, Campath)
Leukemia Trial in Portland (drug, radiation, other)
Terminated
- Leukemia
- Campath
- +3 more
-
Portland, OregonOHSU Knight Cancer Institute
Sep 25, 2017
Acute Myelogenous Leukemia, Lymphoid Leukemia, Chronic Myelogenous Leukemia Trial in Chicago (Fludarabine, Melphalan, Stem
Completed
- Acute Myelogenous Leukemia
- +8 more
- Fludarabine
- +3 more
-
Chicago, IllinoisThe University of Chicago
Oct 7, 2016
Myelodysplastic and Myeloproliferative Disorders, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Houston
Terminated
- Myelodysplastic and Myeloproliferative Disorders
- +7 more
- Campath
- +4 more
-
Houston, Texas
- +1 more
Mar 29, 2016
Chronic Lymphocytic Leukemia Trial in New Hyde Park (Campath)
Terminated
- Chronic Lymphocytic Leukemia
- Campath
-
New Hyde Park, New YorkLong Island Jewish Medical Center
Sep 16, 2015
Systemic Lupus Erythematosus, Systemic Sclerosis Trial in New York (Reduced Intensity Allogeneic Transplant, Fludarabine,
Terminated
- Systemic Lupus Erythematosus
- Systemic Sclerosis
- Reduced Intensity Allogeneic Transplant
- +3 more
-
New York, New YorkColumbia University Medical Center
Feb 6, 2014
Advanced Hematologic Malignancies, Leukemia, Preleukemia Trial in Chicago (Clofarabine, Melphalan, Campath)
Completed
- Advanced Hematologic Malignancies
- +2 more
- Clofarabine
- +3 more
-
Chicago, IllinoisThe University of Chicago
Jan 9, 2014
Preleukemia, Myeloproliferative Disorders, Lymphoma Trial in Chicago (Fludarabine, Melphalan, Campath)
Terminated
- Preleukemia
- +4 more
- Fludarabine
- +2 more
-
Chicago, IllinoisThe Uniiversity of Chicago
Mar 14, 2014
Leukemia Trial in Rouen (Campath, rituximab, cyclophosphamide)
Completed
- Leukemia
- Campath
- +3 more
-
Rouen, FranceCentre Henri Becquerel
Jul 24, 2013